Stimcell Energetics Inc. STME Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001139020-25-000055
cik 1493712
name STIMCELL ENERGETICS INC.
sic 3841
countryba CA
stprba BC
cityba VANCOUVER
zipba V6E 4A4
bas1 820 - 1130 PENDER STREET, WEST
bas2
baph (844) 238-2692
countryma CA
stprma BC
cityma VANCOUVER
zipma V6E 4A4
mas1 820 - 1130 PENDER STREET, WEST
mas2
countryinc US
stprinc NV
ein 383939625
former CELL MEDX CORP.
changed 20141009
afs 4-NON
wksi 0
fye 0531
form 10-Q
period 20250228
fy 2025
fp Q3
filed 20250414
accepted 2025-04-14 13:30:00.0
prevrpt 0
detail 1
instance stme-20250228_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001139020-25-000055 20240229 Profit Loss 119971.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20250228 Accrued Liabilities Current 8803.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240831 Adjustments To Additional Paid In Capital Other 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20250228 Assets 17110.0000 USD 0 us-gaap/2024
0001139020-25-000055 20250228 Comprehensive Income Net Of Tax -246925.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240531 Due To Related Party Current 184243.0000 USD 0 0001139020-25-000055 Related Party Transaction= Due To An Entity Controlled By A Director Of The Company;
0001139020-25-000055 20240531 Due To Related Party Current 5885.0000 USD 0 0001139020-25-000055 Related Party Transaction= Due To Cfo;
0001139020-25-000055 20250228 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations -330.0000 USD 3 us-gaap/2024
0001139020-25-000055 20230831 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20230831 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20240229 Foreign Currency Transaction Gain Loss Unrealized -2118.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240229 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20241130 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20240229 General And Administrative Expense 28313.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240229 Interest Expense 9771.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240531 Liabilities And Stockholders Equity 46122.0000 USD 0 us-gaap/2024
0001139020-25-000055 20250228 Management Fee Expense 22500.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240531 Other Assets Current 1807.0000 USD 0 us-gaap/2024 Fair Value By Asset Class= Receivables Associated With Gst Cell Medx Canada;
0001139020-25-000055 20250228 Proceeds From Related Party Debt 30000.0000 USD 3 us-gaap/2024 Short Term Debt Type= Related Party Loan With Mr Amir;
0001139020-25-000055 20230831 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20231130 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20240229 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20250228 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20250228 Research And Development Expense Increase And Decrease 493.0000 USD 1 0001139020-25-000055
0001139020-25-000055 20250228 Retained Earnings Accumulated Deficit -10642227.0000 USD 0 us-gaap/2024
0001139020-25-000055 20241130 Shares Outstanding 19816272.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20230831 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -2471365.0000 USD 0 us-gaap/2024
0001139020-25-000055 20231130 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 366493.0000 USD 0 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20231130 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -10290277.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20240831 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 366493.0000 USD 0 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20240831 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -10362182.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20241130 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 116010.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20250228 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 169037.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20240229 Stock Issued During Period Value Other 0.0000 USD 1 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20240229 Weighted Average Number Of Shares Outstanding Basic 14724120.0000 shares 1 us-gaap/2024
0001139020-25-000055 20250228 Weighted Average Number Of Shares Outstanding Basic 19816272.0000 shares 3 us-gaap/2024
0001139020-25-000055 20240531 Cash 43415.0000 USD 0 us-gaap/2024
0001139020-25-000055 20250228 Cash 6678.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240229 Comprehensive Income Net Of Tax -22159.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240531 Due To Related Party Current 345.0000 USD 0 0001139020-25-000055 Related Party Transaction= Due To Livc;
0001139020-25-000055 20250228 Due To Related Party Current 326.0000 USD 0 0001139020-25-000055 Related Party Transaction= Due To Livc;
0001139020-25-000055 20250228 Due To Related Party Current 117667.0000 USD 0 0001139020-25-000055 Related Party Transaction= Due To The Ceo;
0001139020-25-000055 20250228 Earnings Per Share Basic -0.0200 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Foreign Currency Transaction Gain Loss Before Tax 100039.0000 USD 3 us-gaap/2024
0001139020-25-000055 20230831 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20231130 Foreign Currency Transaction Gain Loss Unrealized 6420.0000 USD 1 us-gaap/2024
0001139020-25-000055 20241130 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20250228 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20240229 Interest Expense 1314.0000 USD 3 us-gaap/2024 Short Term Debt Type= Loans To A Company David Jeffs Is A Director Of;
0001139020-25-000055 20250228 Interest Expense 27113.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240531 Liabilities 872577.0000 USD 0 us-gaap/2024
0001139020-25-000055 20250228 Net Cash Provided By Used In Financing Activities 46745.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240531 Notes And Advances Due To Related Parties 219757.0000 USD 0 0001139020-25-000055 Short Term Debt Type= Related Party Loans Payable2;
0001139020-25-000055 20250228 Operating Expenses 131086.0000 USD 1 us-gaap/2024
0001139020-25-000055 20250228 Other Assets Current 3082.0000 USD 0 us-gaap/2024 Fair Value By Asset Class= Receivables Associated With Gst Cell Medx Canada;
0001139020-25-000055 20250228 Proceeds From Related Party Debt 8724.0000 USD 3 us-gaap/2024 Short Term Debt Type= Loans To Richard Jeffs;
0001139020-25-000055 20240229 Professional And Contract Services Expense 94796.0000 USD 3 us-gaap/2024
0001139020-25-000055 20230831 Profit Loss -76953.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240229 Profit Loss 119971.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240229 Profit Loss -17529.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240831 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20240831 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20241130 Profit Loss -139508.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240229 Research And Development Expense Increase And Decrease -21084.0000 USD 1 0001139020-25-000055
0001139020-25-000055 20250228 Reserves 366493.0000 USD 0 0001139020-25-000055
0001139020-25-000055 20231130 Shares Outstanding 4194871.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20231130 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 62668.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20240229 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 60550.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20240229 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 8938668.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20240531 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 366493.0000 USD 0 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20240229 Stock Issued During Period Value Other 1622693.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240531 Accrued Liabilities Current 28058.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240531 Additional Paid In Capital 9013501.0000 USD 0 us-gaap/2024
0001139020-25-000055 20250228 Additional Paid In Capital 9016666.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240831 Adjustments To Additional Paid In Capital Other 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20250228 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001139020-25-000055 20250228 Common Stock Shares Authorized 500000000.0000 shares 0 us-gaap/2024
0001139020-25-000055 20240229 Comprehensive Income Net Of Tax 117853.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240531 Due To Related Party Current 231138.0000 USD 0 0001139020-25-000055
0001139020-25-000055 20240229 Foreign Currency Transaction Gain Loss Before Tax -2118.0000 USD 1 us-gaap/2024
0001139020-25-000055 20230831 Foreign Currency Transaction Gain Loss Unrealized -8932.0000 USD 1 us-gaap/2024
0001139020-25-000055 20231130 Foreign Currency Transaction Gain Loss Unrealized 6420.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20231130 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20240229 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20240229 Increase Decrease In Accounts Payable 34851.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240229 Interest Expense 53655.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240229 Interest Expense 4049.0000 USD 3 us-gaap/2024 Short Term Debt Type= Note Payables To Mr Ahdoot;
0001139020-25-000055 20250228 Interest Expense 21.0000 USD 3 us-gaap/2024 Short Term Debt Type= Loans To Susan Jeffs;
0001139020-25-000055 20240531 Notes And Advances Due To Related Parties 324490.0000 USD 0 0001139020-25-000055
0001139020-25-000055 20250228 Notes And Advances Due To Related Parties 388563.0000 USD 0 0001139020-25-000055
0001139020-25-000055 20250228 Notes And Advances Due To Related Parties 283827.0000 USD 0 0001139020-25-000055 Short Term Debt Type= Related Party Loans Payable2;
0001139020-25-000055 20240229 Operating Expenses 57775.0000 USD 1 us-gaap/2024
0001139020-25-000055 20250228 Other Assets Current 7350.0000 USD 0 us-gaap/2024 Fair Value By Asset Class= Prepaid Expenses;
0001139020-25-000055 20250228 Proceeds From Related Party Debt 46745.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Proceeds From Related Party Debt 8021.0000 USD 3 us-gaap/2024 Short Term Debt Type= Loans To Susan Jeffs;
0001139020-25-000055 20230831 Profit Loss -76953.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20240229 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20241130 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20241130 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20241130 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20241130 Profit Loss -139508.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20250228 Profit Loss -140537.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240229 Research And Development Expense Increase And Decrease -20477.0000 USD 3 0001139020-25-000055
0001139020-25-000055 20240531 Shares Outstanding 19816272.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20230531 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 366493.0000 USD 0 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20230831 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 7331429.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20230831 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 4195.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20240831 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 50477.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20250228 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -1070215.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240229 Stock Issued During Period Value New Issues 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20240229 Stock Issued During Period Value Other 1607239.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20240229 Stock Issued During Period Value Other 15454.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20250228 Weighted Average Number Of Shares Outstanding Basic 19816272.0000 shares 1 us-gaap/2024
0001139020-25-000055 20240831 Adjustments To Additional Paid In Capital Other 3165.0000 USD 1 us-gaap/2024
0001139020-25-000055 20250228 Accumulated Other Comprehensive Income Loss Net Of Tax 169037.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240531 Assets 46122.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240229 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 79677.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240531 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 43415.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240531 Common Stock Value 19816.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240229 Earnings Per Share Basic 0.0100 USD 1 us-gaap/2024
0001139020-25-000055 20250228 Foreign Currency Transaction Gain Loss Realized -41552.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240831 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20240831 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20241130 Foreign Currency Transaction Gain Loss Unrealized 65533.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20241130 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20241130 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20241130 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20250228 Foreign Currency Transaction Gain Loss Unrealized 53027.0000 USD 1 us-gaap/2024
0001139020-25-000055 20250228 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20240229 Increase Decrease In Due To Related Parties 23640.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240229 Interest Expense 4386.0000 USD 3 us-gaap/2024 Short Term Debt Type= Advances From David Jeffs;
0001139020-25-000055 20250228 Interest Expense 9451.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240229 Net Cash Provided By Used In Operating Activities -113630.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240531 Notes And Advances Due To Related Parties 93733.0000 USD 0 0001139020-25-000055 Short Term Debt Type= Related Party Loans Payable;
0001139020-25-000055 20240531 Other Assets Current 900.0000 USD 0 us-gaap/2024 Fair Value By Asset Class= Prepaid Expenses;
0001139020-25-000055 20240229 Proceeds From Issuance Or Sale Of Equity 75000.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240229 Professional And Contract Services Expense 35325.0000 USD 1 us-gaap/2024
0001139020-25-000055 20250228 Professional And Contract Services Expense 103331.0000 USD 3 us-gaap/2024
0001139020-25-000055 20230831 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20230831 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20231130 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20231130 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20231130 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20231130 Profit Loss -60547.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20240229 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20240831 Profit Loss -66919.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20241130 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20250228 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20250228 Research And Development Expense Increase And Decrease 493.0000 USD 3 0001139020-25-000055
0001139020-25-000055 20240229 Shares Outstanding 19649092.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20230531 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -2385480.0000 USD 0 us-gaap/2024
0001139020-25-000055 20230831 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 0.0000 USD 0 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20240229 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 366493.0000 USD 0 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20240831 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 0.0000 USD 0 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20241130 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -982705.0000 USD 0 us-gaap/2024
0001139020-25-000055 20241130 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 9016666.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20250228 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 19816.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20250228 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 0.0000 USD 0 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20250228 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -10642227.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20240229 Stock Issued During Period Value New Issues 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20240229 Stock Issued During Period Value New Issues 0.0000 USD 1 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20240229 Stock Issued During Period Value New Issues 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20240229 Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax 31.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240831 Adjustments To Additional Paid In Capital Other 3165.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20240531 Common Stock Shares Authorized 7500000000.0000 shares 0 us-gaap/2024
0001139020-25-000055 20240531 Common Stock Shares Issued 297236373.0000 shares 0 us-gaap/2024
0001139020-25-000055 20240229 Debt Related Commitment Fees And Debt Issuance Costs 10562.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Debt Related Commitment Fees And Debt Issuance Costs 4958.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Due To Related Party Current 0.0000 USD 0 0001139020-25-000055 Related Party Transaction= Due To An Entity Controlled By A Director And A Significant Shareholder;
0001139020-25-000055 20240229 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations 12.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240229 Extinguishment Of Debt Gain Loss Net Of Tax 187517.0000 USD 1 us-gaap/2024
0001139020-25-000055 20250228 Extinguishment Of Debt Gain Loss Net Of Tax 0.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240229 Foreign Currency Transaction Gain Loss Realized 547.0000 USD 3 us-gaap/2024
0001139020-25-000055 20231130 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20240831 Foreign Currency Transaction Gain Loss Unrealized -18521.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20240831 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20241130 Foreign Currency Transaction Gain Loss Unrealized 65533.0000 USD 1 us-gaap/2024
0001139020-25-000055 20250228 Foreign Currency Transaction Gain Loss Unrealized 53027.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20250228 Increase Decrease In Due To Related Parties 163949.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240229 Management Fee Expense 15000.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Notes And Advances Due To Related Parties 10389.0000 USD 0 0001139020-25-000055 Short Term Debt Type= Related Party Advances;
0001139020-25-000055 20240531 Other Assets Current 2707.0000 USD 0 us-gaap/2024
0001139020-25-000055 20250228 Other Assets Current 10432.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240229 Proceeds From Related Party Debt 20000.0000 USD 3 us-gaap/2024
0001139020-25-000055 20231130 Profit Loss -60547.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240229 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20240831 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20240831 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20250228 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20240531 Reserves 366493.0000 USD 0 0001139020-25-000055
0001139020-25-000055 20231130 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 7331429.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20231130 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 4195.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20231130 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 0.0000 USD 0 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20240229 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -10170306.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20241130 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 366493.0000 USD 0 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20250228 Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax -76747.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240531 Accounts Payable Current 288891.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240531 Accumulated Other Comprehensive Income Loss Net Of Tax 68998.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240831 Adjustments To Additional Paid In Capital Other 0.0000 USD 1 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20240831 Adjustments To Additional Paid In Capital Other 0.0000 USD 1 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20240531 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0001139020-25-000055 20250228 Comprehensive Income Net Of Tax -87510.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240229 Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction 43093.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240531 Due To Related Party Current 37500.0000 USD 0 0001139020-25-000055 Related Party Transaction= Due To The Ceo;
0001139020-25-000055 20240229 Earnings Per Share Basic 0.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240229 Extinguishment Of Debt Gain Loss Net Of Tax 187517.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Foreign Currency Transaction Gain Loss Realized -78117.0000 USD 3 us-gaap/2024
0001139020-25-000055 20230831 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20230831 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20240229 Foreign Currency Transaction Gain Loss Unrealized -2118.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20240831 Foreign Currency Transaction Gain Loss Unrealized -18521.0000 USD 1 us-gaap/2024
0001139020-25-000055 20250228 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20250228 General And Administrative Expense 32847.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240229 Increase Decrease In Accrued Liabilities -23465.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Increase Decrease In Accrued Liabilities -19215.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240229 Increase Decrease In Other Current Assets -2766.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240229 Interest Expense 21390.0000 USD 3 us-gaap/2024 Short Term Debt Type= Loans To Richard Jeffs;
0001139020-25-000055 20250228 Interest Expense 5093.0000 USD 3 us-gaap/2024 Short Term Debt Type= Note Payables To Mr Ahdoot;
0001139020-25-000055 20250228 Liabilities And Stockholders Equity 17110.0000 USD 0 us-gaap/2024
0001139020-25-000055 20250228 Professional And Contract Services Expense 33694.0000 USD 1 us-gaap/2024
0001139020-25-000055 20230831 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20230831 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20240229 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20240831 Profit Loss -66919.0000 USD 1 us-gaap/2024
0001139020-25-000055 20250228 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20250228 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20250228 Profit Loss -346964.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Shares Outstanding 19816272.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20230531 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 0.0000 USD 0 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20230531 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -10152777.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20230831 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 56248.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20240229 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -709946.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240531 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 68998.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20240831 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -908730.0000 USD 0 us-gaap/2024
0001139020-25-000055 20250228 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 9016666.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20240229 Stock Issued During Period Shares Other 15454221.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20240229 Stock Issued During Period Value Other 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20240229 Stock Issued During Period Value Other 0.0000 USD 1 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20240229 Weighted Average Number Of Shares Outstanding Basic 7691811.0000 shares 3 us-gaap/2024
0001139020-25-000055 20250228 Accounts Payable Current 310901.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240831 Adjustments To Additional Paid In Capital Other 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20230531 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 98295.0000 USD 0 us-gaap/2024
0001139020-25-000055 20250228 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 6678.0000 USD 0 us-gaap/2024
0001139020-25-000055 20250228 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -36737.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Common Stock Shares Issued 19816272.0000 shares 0 us-gaap/2024
0001139020-25-000055 20240531 Due To Related Party Current 3165.0000 USD 0 0001139020-25-000055 Related Party Transaction= Due To An Entity Controlled By A Director And A Significant Shareholder;
0001139020-25-000055 20250228 Due To Related Party Current 379058.0000 USD 0 0001139020-25-000055
0001139020-25-000055 20240229 Foreign Currency Transaction Gain Loss Before Tax -4630.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Foreign Currency Transaction Gain Loss Before Tax 53027.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240229 Foreign Currency Transaction Gain Loss Realized -221.0000 USD 1 us-gaap/2024
0001139020-25-000055 20231130 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20250228 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20250228 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20250228 Increase Decrease In Accounts Payable 24664.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Increase Decrease In Other Current Assets 7877.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Interest Expense 3274.0000 USD 3 us-gaap/2024 Short Term Debt Type= Advances From David Jeffs;
0001139020-25-000055 20250228 Interest Expense 1390.0000 USD 3 us-gaap/2024 Short Term Debt Type= Loans To A Company David Jeffs Is A Director Of;
0001139020-25-000055 20250228 Interest Expense 2867.0000 USD 3 us-gaap/2024 Short Term Debt Type= Loans To Richard Jeffs;
0001139020-25-000055 20240229 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -18618.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Common Stock Value 19816.0000 USD 0 us-gaap/2024
0001139020-25-000055 20250228 Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction 22155.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Due To Related Party Current 255472.0000 USD 0 0001139020-25-000055 Related Party Transaction= Due To An Entity Controlled By A Director Of The Company;
0001139020-25-000055 20250228 Due To Related Party Current 5593.0000 USD 0 0001139020-25-000055 Related Party Transaction= Due To Cfo;
0001139020-25-000055 20250228 Earnings Per Share Basic -0.0100 USD 1 us-gaap/2024
0001139020-25-000055 20250228 Extinguishment Of Debt Gain Loss Net Of Tax 1569.0000 USD 3 us-gaap/2024
0001139020-25-000055 20230831 Foreign Currency Transaction Gain Loss Unrealized -8932.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20231130 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20231130 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20240229 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20240229 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20240229 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20240831 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20240831 Foreign Currency Transaction Gain Loss Unrealized 0.0000 USD 1 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20240229 General And Administrative Expense 62619.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 General And Administrative Expense 71979.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240229 Interest Expense 8245.0000 USD 3 us-gaap/2024 Short Term Debt Type= Related Party Loan With Mr Amir;
0001139020-25-000055 20240229 Management Fee Expense 15000.0000 USD 1 us-gaap/2024
0001139020-25-000055 20250228 Management Fee Expense 67500.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240229 Net Cash Provided By Used In Financing Activities 95000.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Proceeds From Issuance Or Sale Of Equity 0.0000 USD 3 us-gaap/2024
0001139020-25-000055 20231130 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20240831 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20241130 Profit Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20230531 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 65180.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20230531 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 7331429.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20230531 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 4195.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20230831 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 366493.0000 USD 0 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20230831 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -10229730.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20240229 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 19649.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20240531 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 9013501.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20240531 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 19816.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20250228 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 366493.0000 USD 0 us-gaap/2024 Equity Components= Reserves1;
0001139020-25-000055 20240229 Stock Issued During Period Value New Issues 75000.0000 USD 1 us-gaap/2024
0001139020-25-000055 20240229 Stock Issued During Period Value New Issues 75000.0000 USD 1 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20250228 Interest Expense 9512.0000 USD 3 us-gaap/2024 Short Term Debt Type= Related Party Loan With Mr Amir;
0001139020-25-000055 20250228 Liabilities 1087325.0000 USD 0 us-gaap/2024
0001139020-25-000055 20250228 Net Cash Provided By Used In Operating Activities -83152.0000 USD 3 us-gaap/2024
0001139020-25-000055 20240531 Notes And Advances Due To Related Parties 11000.0000 USD 0 0001139020-25-000055 Short Term Debt Type= Related Party Advances;
0001139020-25-000055 20250228 Notes And Advances Due To Related Parties 94347.0000 USD 0 0001139020-25-000055 Short Term Debt Type= Related Party Loans Payable;
0001139020-25-000055 20240229 Operating Expenses 151391.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Operating Expenses 321420.0000 USD 3 us-gaap/2024
0001139020-25-000055 20250228 Profit Loss -140537.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20240531 Retained Earnings Accumulated Deficit -10295263.0000 USD 0 us-gaap/2024
0001139020-25-000055 20230531 Shares Outstanding 4194871.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20230831 Shares Outstanding 4194871.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20240831 Shares Outstanding 19816272.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20231130 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -2525492.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240229 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 75000.0000 USD 0 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20240531 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -826455.0000 USD 0 us-gaap/2024
0001139020-25-000055 20240531 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 0.0000 USD 0 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20240531 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -10295263.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20240831 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 9016666.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001139020-25-000055 20240831 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 19816.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20241130 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 19816.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20241130 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 0.0000 USD 0 us-gaap/2024 Equity Components= Obligation To Issue Shares;
0001139020-25-000055 20241130 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -10501690.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001139020-25-000055 20240229 Stock Issued During Period Shares New Issues 0.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001139020-25-000055 20240229 Stock Issued During Period Value New Issues 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001139020-25-000055 20240229 Stock Issued During Period Value Other 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Proceeds From Issuance Or Sale Of Equity us-gaap/2024 0 0 monetary D D Proceeds from Issuance or Sale of Equity The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.
Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary I C Equity, Including Portion Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Notes And Advances Due To Related Parties 0001139020-25-000055 1 0 monetary I C Notes and advances due to related parties Represents the monetary amount of Notes and advances due to related parties, as of the indicated date.
Increase Decrease In Due To Related Parties us-gaap/2024 0 0 monetary D D Increase (Decrease) in Due to Related Parties The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Adjustments To Additional Paid In Capital Other us-gaap/2024 0 0 monetary D C Adjustments to Additional Paid in Capital, Other Amount of other increase (decrease) in additional paid in capital (APIC).
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Cash us-gaap/2024 0 0 monetary I D Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Foreign Currency Transaction Gain Loss Unrealized us-gaap/2024 0 0 monetary D C Unrealized Gain (Loss), Foreign Currency Transaction, before Tax Amount, before tax, of unrealized gain (loss) from foreign currency transaction.
Interest Expense us-gaap/2024 0 0 monetary D D Interest Expense, Operating and Nonoperating Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.
Debt Related Commitment Fees And Debt Issuance Costs us-gaap/2024 0 0 monetary D D Debt Related Commitment Fees and Debt Issuance Costs Represents the charge against earnings during the period for commitment fees and debt issuance expenses.
Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Extinguishment Of Debt Gain Loss Net Of Tax us-gaap/2024 0 0 monetary D C Extinguishment of Debt, Gain (Loss), Net of Tax The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax.
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction us-gaap/2024 0 0 monetary D D Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction.
Foreign Currency Transaction Gain Loss Before Tax us-gaap/2024 0 0 monetary D C Gain (Loss), Foreign Currency Transaction, before Tax Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.
Profit Loss us-gaap/2024 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax us-gaap/2024 0 0 monetary D C Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.
Reserves 0001139020-25-000055 1 0 monetary I C Reserves Represents the monetary amount of Reserves, as of the indicated date.
Management Fee Expense us-gaap/2024 0 0 monetary D D Management Fee Expense Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Other Assets Current us-gaap/2024 0 0 monetary I D Other Assets, Current Amount of current assets classified as other.
Stock Issued During Period Shares Other us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Other Number of shares of stock issued attributable to transactions classified as other.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Due To Related Party Current 0001139020-25-000055 1 0 monetary I C Due to related parties - current Represents the monetary amount of Due to related parties - current, as of the indicated date.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Increase Decrease In Other Current Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Current Assets Amount of increase (decrease) in current assets classified as other.
Stock Issued During Period Shares New Issues us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, New Issues Number of new stock issued during the period.
Foreign Currency Transaction Gain Loss Realized us-gaap/2024 0 0 monetary D C Realized Gain (Loss), Foreign Currency Transaction, before Tax Amount, before tax, of realized gain (loss) from foreign currency transaction.
Accounts Payable Current us-gaap/2024 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations us-gaap/2024 0 0 monetary D D Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Disposal Group, Including Discontinued Operations Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; attributable to disposal group, including, but not limited to, discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Increase Decrease In Accounts Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Shares Outstanding us-gaap/2024 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Research And Development Expense Increase And Decrease 0001139020-25-000055 1 0 monetary D D Research and development expense, increase and decrease Represents the monetary amount of Research and development expense, increase and decrease, during the indicated time period.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Proceeds From Related Party Debt us-gaap/2024 0 0 monetary D D Proceeds from Related Party Debt The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.
Professional And Contract Services Expense us-gaap/2024 0 0 monetary D D Professional and Contract Services Expense Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support.
Stock Issued During Period Value New Issues us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
Increase Decrease In Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
Stock Issued During Period Value Other us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Other Value of shares of stock issued attributable to transactions classified as other.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001139020-25-000055 2 3 BS 0 H Cash us-gaap/2024 Cash 0
0001139020-25-000055 2 4 BS 0 H Other Assets Current us-gaap/2024 Other current assets 0
0001139020-25-000055 2 5 BS 0 H Assets us-gaap/2024 Total assets 0
0001139020-25-000055 2 8 BS 0 H Accounts Payable Current us-gaap/2024 Accounts payable 0
0001139020-25-000055 2 9 BS 0 H Accrued Liabilities Current us-gaap/2024 Accrued liabilities 0
0001139020-25-000055 2 10 BS 0 H Due To Related Party Current 0001139020-25-000055 Due to related parties - current 0
0001139020-25-000055 2 11 BS 0 H Notes And Advances Due To Related Parties 0001139020-25-000055 Notes and advances due to related parties 0
0001139020-25-000055 2 12 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0001139020-25-000055 2 13 BS 0 H Common Stock Value us-gaap/2024 Common stock, $0.001 par value, 500,000,000 shares authorized; 19,816,272 shares issued and outstanding at February 28, 2025, and May 31, 2024 0
0001139020-25-000055 2 14 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001139020-25-000055 2 15 BS 0 H Reserves 0001139020-25-000055 Reserves 0
0001139020-25-000055 2 16 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0001139020-25-000055 2 17 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive income 0
0001139020-25-000055 2 18 BS 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Total stockholders' deficit 0
0001139020-25-000055 2 19 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders' deficit 0
0001139020-25-000055 3 1 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common Stock, Par or Stated Value Per Share 0
0001139020-25-000055 3 2 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common Stock, Shares Authorized 0
0001139020-25-000055 3 3 BS 1 H Common Stock Shares Issued us-gaap/2024 Common Stock, Shares, Issued 0
0001139020-25-000055 4 1 IS 0 H Professional And Contract Services Expense us-gaap/2024 Consulting fees 0
0001139020-25-000055 4 2 IS 0 H Foreign Currency Transaction Gain Loss Realized us-gaap/2024 Foreign exchange expense 1
0001139020-25-000055 4 3 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative expenses 0
0001139020-25-000055 4 4 IS 0 H Management Fee Expense us-gaap/2024 Management fee expense 0
0001139020-25-000055 4 5 IS 0 H Research And Development Expense Increase And Decrease 0001139020-25-000055 Research and development expense, increase and decrease 0
0001139020-25-000055 4 6 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0001139020-25-000055 4 8 IS 0 H Extinguishment Of Debt Gain Loss Net Of Tax us-gaap/2024 Gain (loss) on forgiveness of debt 0
0001139020-25-000055 4 9 IS 0 H Interest Expense us-gaap/2024 Interest 1
0001139020-25-000055 4 10 IS 0 H Profit Loss us-gaap/2024 Net income (loss) 0
0001139020-25-000055 4 11 IS 0 H Foreign Currency Transaction Gain Loss Before Tax us-gaap/2024 Foreign currency translation Income (loss) 0
0001139020-25-000055 4 12 IS 0 H Comprehensive Income Net Of Tax us-gaap/2024 Comprehensive income (loss) 0
0001139020-25-000055 4 13 IS 0 H Earnings Per Share Basic us-gaap/2024 Earnings Per Share, Basic 0
0001139020-25-000055 4 14 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted Average Number of Shares Outstanding, Basic 0
0001139020-25-000055 5 11 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Equity Balance 0
0001139020-25-000055 5 12 EQ 0 H Shares Outstanding us-gaap/2024 Equity Balance, Shares 0
0001139020-25-000055 5 13 EQ 0 H Profit Loss us-gaap/2024 Net income (loss) for the period 0
0001139020-25-000055 5 14 EQ 0 H Foreign Currency Transaction Gain Loss Unrealized us-gaap/2024 Translation to reporting currency 0
0001139020-25-000055 5 15 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Equity Balance 0
0001139020-25-000055 5 16 EQ 0 H Shares Outstanding us-gaap/2024 Equity Balance, Shares 0
0001139020-25-000055 5 17 EQ 0 H Stock Issued During Period Value Other us-gaap/2024 Stock issued for debt, value 0
0001139020-25-000055 5 18 EQ 0 H Stock Issued During Period Shares Other us-gaap/2024 Stock issued for debt, shares 0
0001139020-25-000055 5 19 EQ 0 H Stock Issued During Period Value New Issues us-gaap/2024 Stock issued for cash, value 0
0001139020-25-000055 5 20 EQ 0 H Stock Issued During Period Shares New Issues us-gaap/2024 Stock issued for cash, shares 0
0001139020-25-000055 5 21 EQ 0 H Adjustments To Additional Paid In Capital Other us-gaap/2024 Debt forgiven by shareholders, APIC 0
0001139020-25-000055 6 2 CF 0 H Profit Loss us-gaap/2024 Net income (loss) 0
0001139020-25-000055 6 3 CF 0 H Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction us-gaap/2024 Accrued interest on notes payable 0
0001139020-25-000055 6 4 CF 0 H Debt Related Commitment Fees And Debt Issuance Costs us-gaap/2024 Accrued interest on vendor payable 0
0001139020-25-000055 6 5 CF 0 H Extinguishment Of Debt Gain Loss Net Of Tax us-gaap/2024 Gain (loss) on forgiveness of debt 1
0001139020-25-000055 6 6 CF 0 H Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax us-gaap/2024 Unrealized foreign exchange 1
0001139020-25-000055 6 7 CF 0 H Increase Decrease In Other Current Assets us-gaap/2024 Other current assets: 1
0001139020-25-000055 6 8 CF 0 H Increase Decrease In Accounts Payable us-gaap/2024 Accounts payable: 0
0001139020-25-000055 6 9 CF 0 H Increase Decrease In Accrued Liabilities us-gaap/2024 Accrued liabilities: 0
0001139020-25-000055 6 10 CF 0 H Increase Decrease In Due To Related Parties us-gaap/2024 Due to related parties: 0
0001139020-25-000055 6 11 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash flows used in operating activities 0
0001139020-25-000055 6 13 CF 0 H Proceeds From Related Party Debt us-gaap/2024 Proceeds from related party notes 0
0001139020-25-000055 6 14 CF 0 H Proceeds From Issuance Or Sale Of Equity us-gaap/2024 Proceeds from sale of shares 0
0001139020-25-000055 6 15 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by financing activities 0
0001139020-25-000055 6 16 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations us-gaap/2024 Effects of foreign currency exchange on cash 0
0001139020-25-000055 6 17 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Decrease in cash 0
0001139020-25-000055 6 18 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash, beginning 0
0001139020-25-000055 6 19 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash, ending 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.